1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsESCMID Individual Research Grants is sponsored by ESCMID (European Society of Clinical Microbiology and Infectious Diseases). ESCMID's Individual Research Grants offer funding to aspiring young investigators in clinical microbiology and infectious diseases.
Get alerted about grants like this
Get emailed when new opportunities from “ESCMID (European Society of Clinical Microbiology and Infectious Diseases)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Every year, ESCMID allocates around 1 million EUR to propel ground-breaking research projects in the fields of Clinical Microbiology (CM) and Infectious Diseases (ID). ESCMID provides individual research grants to aspiring young investigators and as a part of the ESCMID Study Groups (SGs), a complimentary benefit available to members.
These grants aim to drive collaboration and innovation in CM and ID, positioning ESCMID as a pioneer in the future of healthcare excellence. Individual Research Grants 2027 (Fungal / Parasitic/Viral Infections) Deadline 02 September 2026, 12:00 CEST ESCMID Research Grants help nurture the next generation of researchers in CM and ID, by providing an important start in their research funding journey.
These grants offer a unique opportunity to explore bacterial infections & diseases or fungal/viral/parasitic infections & diseases in alternating years. Within this call, we welcome applications under the new women in science category. ESCMID’s Individual Research Grants offer up to 20K EUR per project.
The grant can be used for the entirety of the project or specific aspects. Upon the signing of the grant agreement, 50% of the allocated funds are issued to the grantee’s institution, with the remaining 50% released upon the submission and approval of the final reports (refer to reporting below for more details).
ESCMID Fördergesellschaft Grants for Research in AMR, Emerging Infections and Vaccines As part of the new ESCMID strategy, the ESCMID Fördergesellschaft Grant enhances funding for research projects focusing on antimicrobial resistance (AMR), emerging infectious diseases (EID) or vaccines (VAX). This support benefits both individual researchers and study groups.
As part of this initiative, six additional grants (two per topic) are awarded annually. To qualify, projects must address the challenges posed by AMR, EID, or VAX aligning with the specified theme for the year. Applications are integrated into the standard grant calls, with clear indications provided in the application form.
ESCMID grants to support women in science Diversity, equity and inclusion are core values of ESCMID. To strengthen the foundation of female early-career researchers, ESCMID awards three additional Individual Research Grants dedicated to supporting women in science. Applicants for the “Women in Science” category are not required to hold an ESCMID membership.
Applications are submitted through the standard grant call. Your research project can include laboratory investigations, clinical studies, experimental animal studies, or a combination of approaches. In 2027, the research grant programme will welcome projects focused on fungal/parasitic/viral infections and diseases.
Projects usually last from 12-24 months, starting from the year the grant is received. Should your project align with the specified criteria, it will undergo a rigorous peer review process, with the most promising projects being selected through a meticulous ranking of applications and research proposals. Please note that projects that do not align with the established criteria will be disqualified without a peer review.
Qualify for a research grant opportunity by meeting the following criteria: Serve as the principal investigator for the proposed research project Hold a valid ESCMID Young Scientist Membership (YSM) or ESCMID low- or middle-income country (LMIC) membership* ** Have a medical degree (MD, MBBS, PharmD, or equivalent), a PhD, or be actively enrolled in a PhD programme Applicants who have received any ESCMID Research Grant (Individual, Study Group or SG Collaboration) may only apply for a subsequent grant in the year after official completion of the first project.
Additionally, you cannot be awarded more than one ESCMID Research Grant (Individual, Study Group or SG Collaboration) in a single year or be listed as principal investigator in more than one concurrent project. Please be aware that members of the ESCMID Executive Committee (EC) are not eligible to apply for research grants or provide support letters for applications.
*ESCMID invites ESCMID LMIC members to apply if they are still in training or completing their training (PhD no more than eight years post-graduation, MD or MD/PhD no more than five years from completion of clinical training or speciality).
If this opportunity sparks your interest, you are encouraged to contact the ESCMID Office and submit documents proving your status as early as possible, no later than two weeks before the application deadline. **Applicants for the “Women in Science” category are not required to hold an ESCMID membership. You are welcome to apply if you meet the above criteria.
To ensure an efficient application process, all documentation must be submitted electronically via the online application form. As you prepare to submit, please have the following documents readily available. A single PDF document (labelled “YourSurname”.
pdf; in Calibri font, size 11, with 2 cm margins, max. 4MB) including the following key elements: Abstract of your research project (max. 750 words; with 3-5 keywords that best characterise your project).
Please also include the abstract and keywords separately in the online form (in addition to including them in the PDF document) to help facilitate reviewer selection. Introduction/Background (max. 500 words) Objectives (max.
300 words) Purpose and potential impact of your project (max. 700 words) Research plan (max. 2,000 words) including design, material and methods, data analysis, project timeline, co-investigators and their contribution to the project; references/bibliography can be included here and are not included in the word limit Budget including personnel, equipment and consumables (max.
1,500 words; please use tables wherever possible) Description of your present research (max. 750 words) Your CV (max. 1,500 words) demonstrating how your skills align with the project's requirements.
Alternatively, support letters must confirm that adequate mentoring is available to ensure the project’s success. It is advised to discuss with your supporters to determine the most suitable strategy for your situation. Your publication list , highlighting your most relevant publications from the past five years to help reviewers assess your experience and competencies in relation to the project you are submitting (max.
10) Two signed letters of support (labelled “YourSurname”_support1. pdf and “YourSurname”_support2. pdf; max.
4MB each). The supporters you select should know you professionally and be able to judge your work. They may include an advisor of yours during training, or any other previous collaboration partners, but cannot be your current direct supervisor and/or anyone from your same department.
Projects missing signed letters of support will not be accepted Potential reviewers: As part of the application process, at least two suitable reviewers should be suggested. Conditions for reviewers include not being directly involved in the project proposal, not having the same affiliation as you, and if possible, not from the same country either.
Should there be any individual you prefer not to have as a reviewer, kindly inform ESCMID accordingly. A colour photograph (labelled “YourSurname_Firstname”. tiff, .
eps or . jpg; max. 4MB), measuring at least 4 x 6 cm with a 300 dpi resolution, suitable for publication.
You can ensure a smooth submission process by first verifying you have the correct documents and file types before uploading. After the deadline, changes to your submission cannot be made, so it is strongly recommended to ensure all details are correct before submitting.
Here are some helpful guidance for writing your research grant application: Write as concisely as possible, you do not need to reach the maximum word counts Use bullet points to facilitate review If English is not your first language, consider having your text proofread before submission Clearly specify where funding will be used if your project is selected for a grant, especially if your project combines different funding sources (please note that omission will lead to rejection) Within six months following the completion of your project, you must submit your financial and scientific reports.
ESCMID can provide you with templates and thorough guidelines to support your report writing. Your financial report should illustrate a full breakdown of how the provided funds were used, accompanied by the signature of your head of department.
Your scientific report should capture your research journey in a maximum of 1,000 words, covering the key elements listed below: A short introduction summarising the current level of knowledge for non-specialists An overview of what was funded by your ESCMID Grant A summary of the main findings – potentially including how the data contributed to other projects A conclusion on your findings Should a published scientific article accompany your report, you are welcome to submit a concise version of your report, with references directing to the relevant sections within the article.
For transparency, the article should disclose any funding from alternative sources. Financial report template Scientific report template Grant recipients must acknowledge ESCMID in all scientific publications using the wording “This study/project has been funded by a European Society of Clinical Microbiology and Infectious Diseases (ESCMID) research grant to (initials of grantee) in (year of grant)”.
Grant recipients should first consider publishing in one of the Society’s official journals Clinical Microbiology and Infection (CMI) or CMI Communications for initial submission of manuscripts, but alternative journals may be considered depending on the scope of the project.
Please share with the ESCMID Office any published scientific articles stemming from your grant-funded projects, regardless of whether the project has concluded, even after all reports have been submitted. These articles are a source of pride for the Society and will be continuously showcased on the website and in the annual ESCMID yearbook.
In this way, ESCMID will be able to keep celebrating your research accomplishments and contribution to the global advancement of knowledge in the fields of CM and ID. Study Group Research Grants Deadline 22 July 2026, 12:00 CEST (noon) Dive into cutting-edge research with ESCMID Study Group research grants, tailored for CM and ID related projects.
Study groups cover a vast range of themes, ensuring that there is no limit to the topics eligible for funding each year. Membership of a study group is free and open to all ESCMID members, and will propel your research to new heights of excellence. With up to 30K EUR offered to cover project costs, ESCMID SG research grants can help you support the entirety or specific elements of your project.
Upon signing, ESCMID will assign the designated grant amount. This sum can be used to settle invoices or be transferred directly to your institution for the project's needs.
ESCMID Fördergesellschaft Grants for Research in AMR and Emerging Infections As part of the new ESCMID strategy, the ESCMID Fördergesellschaft Grant enhances funding for research projects focusing on antimicrobial resistance (AMR) or emerging infectious diseases (EID). This support benefits both individual researchers and study groups. As part of this initiative, two additional grants are awarded annually.
To qualify, projects must address the challenges posed by AMR and/or EID, aligning with the specified theme for the year. Applications are integrated into the standard grant calls, with clear indications provided in the application form. Your research project can encompass a range of dynamic approaches, including laboratory investigations, clinical studies, experimental animal studies, or a combination of these approaches.
In the spirit of collaboration, your research project should be conducted in partnership with at least two separate institutions across two different countries. Projects should be high quality, focussing on innovation and designed for a maximum duration of two years and they should start after the grant agreement is signed. The full support and engagement of all SGs involved is mandatory.
Applicants who have received any ESCMID Research Grant (Individual, Study Group or SG Collaboration) may only apply for a subsequent grant in the year after the official completion of the first project. Additionally, you cannot be awarded more than one ESCMID Research Grant (Individual, Study Group or SG Collaboration) in a single year or be listed as principal investigator (PI) in more than one concurrent project.
Please be aware that members of the ESCMID Executive Committee (EC) and the ESCMID Scientific Affairs Subcommittee (SAS) are not eligible to apply for research grants or provide support letters for applications. Qualify for our research grant opportunities by meeting the following criteria.
Each SG may apply with a maximum of two research projects, as indicated below: Either one project as a single SG applicant + one project in collaboration with another SG Or two projects, each in collaboration with another SG Two projects as a single SG cannot be accepted as these grants aim to boost interconnectivity across a wide range of topic areas.
These limitations apply to all SG projects proposed, independent of their eligibility for the Förderverein Grant.
As the applicant, you should be the principal investigator for the proposed research Each SG involved should also fully support the proposal by written approval of their respective study group EC To qualify, you should be an ESCMID Full, LMIC or YSM, and a member of at least one of the involved SG To ensure an efficient application process, all documentation must be submitted electronically via the online application form.
As you prepare to submit, please have the following documents readily available: The completed SG Research Grant application form based on the criteria above (labelled “YourSurname”_application. pdf; max 4MB) A support letter (labelled “YourSurname_support”. pdf; max 4MB) signed by the Chairperson, Secretary, and Treasurer of the SG involved in the proposal.
The letter should clearly state the title of your project, your name as the applicant, and your respective SG. Importantly, where collaboration between two study groups will be occurring, a single scanned file containing two support letters, one for each involved study group, is required. A colour photograph (labelled “YourSurname_Firstname”.
tiff, . eps or . jpg; max 4MB), measuring at least 4 x 6 cm with a 300 dpi resolution, suitable for publication.
You can ensure a smooth submission process by first verifying you have the correct documents and file types before uploading. After the deadline, changes to your submission cannot be made, so it is strongly recommended to ensure all details are correct before submitting.
The Scientific Affairs Subcommittee (SAS) and potentially external peer-reviewers will be taking an extensive look at your proposal, focusing on the following key areas: Scientific and/or technological excellence: The soundness of the concept and quality of the objectives State-of-the-art progress Quality and effectiveness of the scientific/technological methodology and work plan Quality and efficiency of implementation and budgeting: Overall appropriateness of collaborating partners Overall quality and relevant experience of individual partners Overall suitability and justification of the grant resources for the respective project (budget, staff and equipment) Overall timing and scope of work Geographic distribution of partners When making the final decision, please note that ESCMID may consider other concurrently submitted projects as well as previously approved or ongoing projects within the same SG.
Within 6 months following the completion of your project, you must submit your two-page report summarising your findings.
Here is what the report should include: Summary overview: a short introduction for non-specialists recapping the current level of knowledge on the topic and any gaps which prompted the research Conclusions from the investigation Presentations or publications originating from this project (oral/poster) If peer-reviewed publications covering the funded project are published, please disregard the above report requirement.
Further information, together with the ESCMID templates for the scientific and financial reports, will be provided after signing the grant agreement. Grant recipients must acknowledge ESCMID in all scientific publications using the wording “This study/project has been funded by a European Society of Clinical Microbiology and Infectious Diseases (ESCMID) research grant to (initials of grantee) in (year of grant)”.
Grant recipients should first consider publishing in one of the Society’s official journals Clinical Microbiology and Infection (CMI) or CMI Communications for initial submission of manuscripts, but alternative journals may be considered depending on the scope of the project.
Please share with the ESCMID Office any published scientific articles stemming from your grant-funded projects, regardless of whether the project has concluded, even after all reports have been submitted. These articles are a source of pride for the Society and will be continuously showcased on the website and in the annual ESCMID yearbook.
In this way, ESCMID will be able to keep celebrating your research accomplishments and contribution to the global advancement of knowledge in the fields of CM and ID. Study Group Collaboration Grant The Study Group Collaboration Grant is a larger-scale grant for innovative research projects in CM and ID organised by an experienced PI with the support of at least three collaborating ESCMID SGs.
Please do not apply, if you do not have full support from three or more of ESCMID's SGs. SG membership is free and open to all ESCMID members. There is currently no opening planned for this grant.
The maximum amount granted per project is 180K EUR and includes any potential overhead costs charged by your institution. ESCMID’s funding may support the entire project or part of it. After signing the grant agreement, ESCMID will set aside the amount that can either be used to pay invoices or be transferred to your institution for project use.
ESCMID believes collaboration is key, so your project must be supported by at least three ESCMID SGs and be carried out in partnership with institutions from at least two different countries. In addition, each project should include members from each participating SG, ensuring diverse expertise and participation.
Your research should encompass a broad range of methodologies, including laboratory investigations, clinical studies, and experimental animal research. Projects should be high quality focussing on innovation and networking, designed for a maximum duration of two years. Please note, that projects which do not align with the established criteria will be disqualified without a peer review.
Qualify for ESCMID's research grant opportunities by meeting the following criteria: Be the principal investigator for the proposed research, with previous experience in conducting large research projects Have the full support of the Chairperson, Secretary, and Treasurer of each SG, with their written approval Be an active ESCMID Full, YSM, or LMIC member Please note that applications are not accepted from companies/start-up research firms.
Applicants who have received any ESCMID Research Grant (Individual, Study Group or SG Collaboration) may only apply for a subsequent grant in the year after the official completion of the first project. Additionally, you cannot be awarded more than one ESCMID Research Grant (Individual, Study Group or SG Collaboration) in a single year or be listed as principal investigator in more than one concurrent project.
Please be aware that members of the ESCMID Executive Committee (EC) and the ESCMID Scientific Affairs Subcommittee (SAS) are not eligible to apply for research grants or provide support letters for applications. To ensure an efficient application process, all documentation must be submitted electronically via the online application form.
As you prepare to submit, please ensure the following documents are readily available: Completed application form based on the criteria above (labelled “YourSurname”_application. pdf; max 4MB) Your CV as the primary investigator along with the list of your top 10 publications (labelled “YourSurname”_CV.
pdf; max 4MB) (max 2 pages) Support letters signed by the Chairperson, Secretary, and Treasurer of the SGs involved in the proposal (electronic signatures allowed). The letters must include the title of the project, your name as the applicant, and the SGs involved (labelled “YourSurname”_support. pdf; max 4MB).
A colour photograph (labelled “YourSurname_Firstname”. tiff, . eps or .
jpg; max 4MB), measuring at least 4 x 6 cm with a 300 dpi resolution, suitable for publication Optional : supplemental data or graphical abstracts to support the proposal (PDF format; max 4 MB) SGs can be part of multiple submissions.
The SAS and potentially external peer reviewers will be taking an extensive look at your proposal, focusing on the following key areas: Your research project should include a translational component The roles of each SG should be clearly defined, and responsibilities appropriately split Clarity and objectives of the proposal (10 points) Importance and relevance to ID and CM (10 points) Adequacy of preliminary work (10 points) Suitability of methods for the project (10 points) Innovation of the proposal (10 points) Sufficiency of research infrastructure for success (10 points) Scientific excellence and proposal feasibility (10 points) Inclusion and appropriateness of external collaborators (5 points) Priority for projects with partners in low- or lower-middle-income countries* (5 points).
*As defined by the World Bank classification Clear definition of all funding sources and realistic pricing for consumables, equipment, and personnel (10 points) Clear definition of the team and their roles (5 points) Realistic and detailed proposed timeline (5 points) Total possible score: 100 points ESCMID appreciates high-quality applications aligned with the scoring criteria outlined above.
Innovation and networking are key, and as such, ESCMID looks forward to seeing how your projects incorporate these elements. If it is judged that none of the applications for a given year meet the quality standards, ESCMID may decide to withhold funding. Within 6 months following the completion of your project, you must submit your two-page report summarising your findings.
Here is what the report should include: Summary overview: a short introduction for non-specialist readers summarising the current level of knowledge on the topic at hand, and any gaps which prompted the research Conclusions from the investigation Presentations or publications originating from this project (oral/poster) If peer-reviewed publications covering the funded project are published, please disregard the above report requirement.
Further information, together with the ESCMID templates for the scientific and financial reports, will be provided after signing the grant agreement. Grant recipients must acknowledge ESCMID in all scientific publications using the wording “This study/project has been funded by a European Society of Clinical Microbiology and Infectious Diseases (ESCMID) research grant to [initials of grantee] in [year of grant]”.
Grant recipients should first consider publishing in one of the Society’s official journals Clinical Microbiology and Infection (CMI) or CMI Communications for initial submission of manuscripts, but alternative journals may be considered depending on the scope of the project.
Please share with the ESCMID Office any published scientific articles stemming from your grant-funded projects, regardless of whether the project has concluded, even after all reports have been submitted. These articles are a source of pride for the Society and will be continuously showcased on the website and in the annual ESCMID yearbook.
In this way, ESCMID will be able to keep celebrating your research accomplishments and contribution to the global advancement of knowledge in the fields of CM and ID.
According to the current listing, eligibility includes: Aspiring young investigators in clinical microbiology and infectious diseases. Specific eligibility for the 'women in science' category is also mentioned. Confirm the full requirements in the official notice before applying.
The current listing shows up to 20,000 EUR per project. Verify award ceilings, matching requirements, and allowable costs in the official notice.
ESCMID Individual Research Grants is funded by ESCMID (European Society of Clinical Microbiology and Infectious Diseases). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
PAR-26-042 funds NLM-priority clinical informatics R01 grants up to $250,000 in direct costs per year through March 6, 2029, with standard NIH cycles on October 5, February 5, and June 5. The notice explicitly defines non-responsive applications: incremental tool improvements, projects primarily focused on social determinants of health, and projects primarily focused on ethical/legal/social issues. With NIH SBIR/STTR just reopened and the OMB Uniform Grants Regulation rewrite reshaping discretionary awards, the NLM clinical informatics line is one of the few stable, well-defined biomedical funding streams left at the agency. Here is how to read it.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article